ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1611

Mitochondrial Structural Alterations in Fibromyalgia – A Pilot Electron Microscopy Study

Linoy Israel1, Victoria Furer2, Atan Gross1 and Jacob Ablin2, 1Weizmann Institute of Science, Rehovot, Israel, 2Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

Meeting: ACR Convergence 2023

Keywords: fibromyalgia, Mitochondrial Dysfunction

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: Abstracts: Fibromyalgia & Other Clinical Pain Syndromes

Session Type: Abstract Session

Session Time: 2:00PM-3:30PM

Background/Purpose: Fibromyalgia (FM) is among the most common chronic pain conditions, clinically characterized by widespread pain and fatigue. FM pathogenesis remains unknown, leading to challenges in diagnosis and treatment. Mitochondria are the headquarters of cellular energy metabolism and their malfunction has been proposed to contribute to both fibromyalgia and chronic fatigue. Thus, the aim of the current study was to detect structural changes in mitochondria of peripheral blood mononuclear cells (PBMCs) of FM patients, using transmission electron microscopy (TEM).

Methods: To detect mitochondrial structural alterations in FM patients, we analyzed PBMCs from seven FM patients and seven healthy controls using TEM. Patients were recruited from a specialized fibromyalgia clinic at a tertiary hospital. After providing informed consent, patients responded to questionnaires, including the Widespraede Pain Index (WPI) and the symptom severity Scale (SSS), to verify a diagnosis of FM according to ACR criteria. Subsequently, blood samples were drawn and PBMCs were collected for EM analysis.

Results: TEM analysis of PBMCs showed several distinct mitochondrial patterns, including total loss of normal crista in FM patients (Fig. 1). The number of mitochondria with intact crista morphology was reduced in FM patients and the percentage of mitochondria that completely lacked crista was significantly increased. These results correlated with WPI severity. Moreover, in FM patient samples we observed a high percentage of cells containing “black-particles” (Fig. 2), which may represent ribosomal aggregates. Crista loss and possible ribosome aggregation were intercorrelated, and thus may represent reactions to a shared cellular stress condition. These changes may indicate an adaptive hypometabolic “hibernation-like” state to a stressful event, similar to hibernation in some mammalian species. The changes in mitochondria morphology suggest that mitochondrial dysfunction, resulting in inefficient respiration, Reactive Oxygen Species generation, etc., may play a pathogenetic role in FM.

Conclusion: We here describe novel morphological changes in mitochondria of FM patients, including loss of mitochondrial crista. While these observations cannot determine whether the changes are pathogenetically primary, or represent an epiphenomenon, they highlight the possibility that mitochondrial malfunction may play a causative role in the cascade of events leading to chronic pain and fatigue in FM. Moreover, the results offer the possibility of utilizing changes in mitochondrial morphology as an objective biomarker in FM. Further understanding the connection between FM and mitochondria morphology, function, and turnover (biogenesis/mitophagy), may assist in developing both novel diagnostic tools as well as specific treatments for FM.

Supporting image 1

TEM of PBMCs, Healthy controls, showing normal mitochondrial crista (A) vs. FM with partial or complete loss of crista (B).

Supporting image 2

Supporting image 3

TEM from FM patient PBMCs, showing stages of accumulation of “black particles (Size bars = 1 m). Right: high magnification of the particles (100 m).


Disclosures: L. Israel: None; V. Furer: None; A. Gross: None; J. Ablin: None.

To cite this abstract in AMA style:

Israel L, Furer V, Gross A, Ablin J. Mitochondrial Structural Alterations in Fibromyalgia – A Pilot Electron Microscopy Study [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/mitochondrial-structural-alterations-in-fibromyalgia-a-pilot-electron-microscopy-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mitochondrial-structural-alterations-in-fibromyalgia-a-pilot-electron-microscopy-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology